ASCENDIS PHARMA A/S shareholders Q2 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q2 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.

ASCENDIS PHARMA A/S shareholders Q2 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 10,000$892,5000.13%
Verition Fund Management LLC 110,058$9,822,6770.13%
PUTNAM INVESTMENTS LLC 899,832$80,310,0060.12%
Candriam S.C.A. 148,375$13,242,4690.10%
BROWN ADVISORY INC 496,882$44,346,7570.07%
DUALITY ADVISERS, LP 6,088$543,3540.07%
SEI INVESTMENTS CO 410,384$36,626,7140.06%
Ergoteles LLC 13,511$1,205,8570.06%
WELLINGTON MANAGEMENT GROUP LLP 3,148,900$281,039,3270.05%
FRANKLIN RESOURCES INC 1,213,325$108,289,2620.05%
Caption Management, LLC 32,500$2,900,6250.05%
Capital International Investors 1,995,271$178,077,9370.04%
SECTORAL ASSET MANAGEMENT INC 2,796$249,5430.04%
XTX Topco Ltd 2,641$235,7090.04%
FMR LLC 5,140,805$458,816,8460.04%
Avior Wealth Management, LLC 6,363$567,8970.04%
PRELUDE CAPITAL MANAGEMENT, LLC 6,400$571,2000.04%
Chicago Partners Investment Group LLC 7,288$665,3220.04%
Allspring Global Investments Holdings, LLC 224,519$20,038,4420.03%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1,087,522$97,061,3390.03%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q2 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.